Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
2.
J Gen Virol ; 81(Pt 2): 327-34, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10644830

ABSTRACT

Recently, alpha6 integrin has been proposed as the epithelial cell receptor for papillomavirus. This study investigated whether alpha6 integrin is the cellular receptor for bovine papillomavirus type 4 (BPV-4), which is strictly epitheliotropic and infects the mucous epithelium of the upper digestive tract. Primary bovine mucosal keratinocytes from the palate of a foetus (PalK) displayed high levels of alpha6 integrin; matched primary fibroblasts from the same biopsy (PalF) expressed almost no alpha6 integrin. However, BPV-4 bound both PalK and PalF to similar, saturable levels. Native BPV-4 virions infected PalK in vitro, as detected by RT-PCR of E7 RNA. Infection could be blocked by excess virus-like particles (VLPs) and by neutralizing antisera against L1-L2 and L1 VLPs or by denaturation of the virions, supporting the view that infection in vitro mimics the process in vivo. alpha6 integrin-negative human keratinocyte cell lines were derived from patients affected by junctional epidermolysis bullosa presenting genetic lesions in their hemidesmosomes. The level of alpha6 integrin expression was determined in these cell lines by in situ immunofluorescence and FACS. Despite the absence of alpha6 integrin expression by BO-SV cells, they were bound by BPV-4 to similar, saturable levels as normal keratinocytes, KH-SV. Furthermore, BO-SV and KH-SV cells were both infected by BPV-4 to apparently the same extent as PalK cells. These results are consistent with the conclusion that alpha6 integrin is not the obligatory receptor for a bovine mucosotropic papillomavirus.


Subject(s)
Antigens, CD/physiology , Bovine papillomavirus 1/pathogenicity , Receptors, Virus/physiology , Animals , Base Sequence , Bovine papillomavirus 1/genetics , Bovine papillomavirus 1/physiology , Bovine papillomavirus 4 , Cattle , Cell Line , Cells, Cultured , DNA Primers/genetics , Epidermolysis Bullosa, Junctional/immunology , Humans , Integrin alpha6 , Keratinocytes/immunology , Keratinocytes/virology , Papillomaviridae/pathogenicity , Papillomaviridae/physiology , Papillomavirus Infections/etiology , Tumor Virus Infections/etiology
4.
J Clin Invest ; 99(4): 635-42, 1997 Feb 15.
Article in English | MEDLINE | ID: mdl-9045865

ABSTRACT

Ultraviolet (UV) radiation is the main physiological stimulus for human skin pigmentation. Within the epidermal-melanin unit, melanocytes synthesize and transfer melanin to the surrounding keratinocytes. Keratinocytes produce paracrine factors that affect melanocyte proliferation, dendricity, and melanin synthesis. In this report, we show that normal human keratinocytes secrete nitric oxide (NO) in response to UVA and UVB radiation, and we demonstrate that the constitutive isoform of keratinocyte NO synthase is involved in this process. Next, we investigate the melanogenic effect of NO produced by keratinocytes in response to UV radiation using melanocyte and keratinocyte cocultures. Conditioned media from UV-exposed keratinocytes stimulate tyrosinase activity of melanocytes. This effect is reversed by NO scavengers, suggesting an important role for NO in UV-induced melanogenesis. Moreover, melanocytes respond to NO-donors by decreased growth, enhanced dendricity, and melanogenesis. The rise in melanogenesis induced by NO-generating compounds is associated with an increased amount of both tyrosinase and tyrosinase-related protein 1. These observations suggest that NO plays an important role in the paracrine mediation of UV-induced melanogenesis.


Subject(s)
Keratinocytes/metabolism , Keratinocytes/radiation effects , Melanins/biosynthesis , Nitric Oxide/biosynthesis , Cell Division/drug effects , Cell Size/drug effects , Cells, Cultured , Culture Media, Conditioned , Dendrites , Humans , Keratinocytes/enzymology , Melanins/metabolism , Melanocytes/cytology , Melanocytes/drug effects , Nitric Oxide/physiology , Nitric Oxide/radiation effects , Nitric Oxide Synthase/chemistry , Ultraviolet Rays
5.
J Biol Chem ; 271(45): 28052-6, 1996 Nov 08.
Article in English | MEDLINE | ID: mdl-8910416

ABSTRACT

Ultraviolet B (UVB) radiation is the main physiological stimulus for human skin pigmentation; however, the molecular mechanisms underlying this process are still unclear. Recently, nitric oxide (NO) and cGMP have been involved in mediation of skin erythema induced by UVB. Therefore, we investigated the role of NO and cGMP in UVB-induced melanogenesis. In this study, we demonstrated that UVB stimulation of melanogenesis was mimicked by exogenous NO donors. Additionally, we showed that NO stimulated cGMP synthesis and that cGMP was also a potent stimulator of melanogenesis. Furthermore, the inhibition of the melanogenic effect of NO by guanylate cyclase inhibitor demonstrated that NO mediated its effect through the activation of guanylyl cyclase. Interestingly, 1 min after UVB irradiation, we observed a significant increase in cGMP content in melanocytes. The effects of UVB on cGMP production and on melanogenesis were blocked by both guanylate cyclase and NO synthase inhibitors. Additionally, inhibition of cGMP-dependent kinase also prevented the stimulation of melanogenesis by UVB and NO. Therefore, we concluded that NO and cGMP production is required for UVB-induced melanogenesis and that cGMP mediated its melanogenic effects mainly through the activation of cGMP-dependent kinase.


Subject(s)
Cyclic GMP/metabolism , Melanins/biosynthesis , Melanocytes/radiation effects , Nitric Oxide/metabolism , Signal Transduction , Ultraviolet Rays , Aminoquinolines/pharmacology , Cyclic GMP/analogs & derivatives , Cyclic GMP/pharmacology , Enzyme Inhibitors/pharmacology , Humans , Melanocytes/drug effects , Melanocytes/metabolism , NG-Nitroarginine Methyl Ester/pharmacology , Nitroprusside/pharmacology , Penicillamine/analogs & derivatives , Penicillamine/pharmacology , S-Nitroso-N-Acetylpenicillamine
SELECTION OF CITATIONS
SEARCH DETAIL